18 percent of Americans say they would quit their job over vaccine, mask mandates
Employed Americans said they are most likely to quit a job immediately if faced with COVID-19 vaccination and/or mask mandates, a new Morning Consult poll reveals.
When asked to describe something their employer could do to make them submit their resignation on the spot, 18 percent of respondents mentioned "vaccine, mask, or testing requirements," even without Morning Consult having mentioned COVID-19 in the prompt. The second-most cited reason was pay cuts — 14 percent of respondents said they would quit if their employer reduced their salary "for no good cause or reason."
Notably, the 18 percent opposed to vaccination and mask mandates "skews heavily Republican compared with the poll's broader sample of working Americans, and is also less likely to have graduated from college." Of the 18 percent, just under half — 47 percent — are Republicans, and 76 percent forwent higher education.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Executives are attempting to navigate the "difficult terrain" of vaccination mandates, which could "impact not only their employer branding, but the health and safety of their staff," writes Morning Consult.
"You take a reputational risk upfront, but you may be saving yourself from an outbreak of the infection later," said Anna Tavis, a clinical associate professor and academic director at the New York University School of Professional Studies Division of Programs in Business. "Employers are going to be weighing the risks of losing a certain percentage of their employees, but at the same time, protecting the rest."
Morning Consult surveyed 1,119 and 1,067 working Americans from June 23-27, 2021. The latter group has a margin of error of three percentage points. See more results at Morning Consult.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK Published
-
The battle for 21st century naturism laid bare
In The Spotlight Nudist lifestyle falling out of favour in Germany but naked attraction is on the rise in the UK
By Chas Newkey-Burden, The Week UK Published
-
The Week Unwrapped: Why do young people love ASMR?
Podcast Plus can US football stamp out homophobia? And why is Scottish Gallic getting a TV boost?
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published